ES498938A0 - Procedimiento para la preparacion de corticoides de anillo a reducido. - Google Patents

Procedimiento para la preparacion de corticoides de anillo a reducido.

Info

Publication number
ES498938A0
ES498938A0 ES498938A ES498938A ES498938A0 ES 498938 A0 ES498938 A0 ES 498938A0 ES 498938 A ES498938 A ES 498938A ES 498938 A ES498938 A ES 498938A ES 498938 A0 ES498938 A0 ES 498938A0
Authority
ES
Spain
Prior art keywords
corticoids
procedure
preparation
ring
reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES498938A
Other languages
English (en)
Other versions
ES8300342A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ES498938A0 publication Critical patent/ES498938A0/es
Publication of ES8300342A1 publication Critical patent/ES8300342A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES498938A 1980-01-31 1981-01-29 Procedimiento para la preparacion de corticoides de anillo a reducido. Expired ES8300342A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/117,401 US4318853A (en) 1980-01-31 1980-01-31 9β,11β-Epoxy-5β-corticoids

Publications (2)

Publication Number Publication Date
ES498938A0 true ES498938A0 (es) 1982-11-01
ES8300342A1 ES8300342A1 (es) 1982-11-01

Family

ID=22372732

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498938A Expired ES8300342A1 (es) 1980-01-31 1981-01-29 Procedimiento para la preparacion de corticoides de anillo a reducido.

Country Status (18)

Country Link
US (1) US4318853A (es)
JP (1) JPS56122398A (es)
KR (1) KR850001208B1 (es)
AU (1) AU538883B2 (es)
BE (1) BE887323A (es)
CA (1) CA1155108A (es)
CH (1) CH644614A5 (es)
DE (1) DE3102397A1 (es)
DK (1) DK39281A (es)
ES (1) ES8300342A1 (es)
FR (1) FR2475048A1 (es)
GB (1) GB2070016B (es)
GR (1) GR73511B (es)
IT (1) IT1193576B (es)
NL (1) NL8100467A (es)
PH (2) PH16525A (es)
SE (1) SE8100563L (es)
ZA (1) ZA8118B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
JP2545522B2 (ja) * 1985-10-23 1996-10-23 アルコン・ラボラトーリーズ，インコーポレイテッド テトラヒドロ脈管形成抑制ステロイド
NL8900507A (nl) * 1989-03-02 1990-10-01 Philips Nv Versterkerschakeling met verzadigingsdetectie.
CA2139549A1 (en) * 1994-01-28 1995-07-29 Kazumi Ogata Corticoid derivatives and pharmaceutical and cosmetic compositions
GB2302807A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Method and composition for treating atopic eczema
DE19737348C2 (de) 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831874A (en) * 1954-04-20 1958-04-22 Gnrd Patent Holdings Ltd Improvements in the preparation of 17:21-diacyloxy-2:4-dibromo-3:11:20-triketoallopregnanes
US2854465A (en) * 1955-02-18 1958-09-30 Ciba Pharm Prod Inc Process for the manufacture of halogen-pregnanes and dehalogenation products thereof
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
US3681410A (en) * 1970-08-07 1972-08-01 Syntex Corp Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof

Also Published As

Publication number Publication date
BE887323A (fr) 1981-07-30
JPS56122398A (en) 1981-09-25
GB2070016A (en) 1981-09-03
FR2475048B1 (es) 1984-11-16
FR2475048A1 (fr) 1981-08-07
SE8100563L (sv) 1981-08-01
DK39281A (da) 1981-08-01
US4318853A (en) 1982-03-09
KR830005263A (ko) 1983-08-03
NL8100467A (nl) 1981-09-01
DE3102397A1 (de) 1981-12-24
IT8119360A0 (it) 1981-01-27
IT1193576B (it) 1988-07-08
GR73511B (es) 1984-03-07
KR850001208B1 (ko) 1985-08-20
AU538883B2 (en) 1984-08-30
GB2070016B (en) 1983-09-14
CH644614A5 (de) 1984-08-15
AU6651381A (en) 1981-08-06
ES8300342A1 (es) 1982-11-01
PH16525A (en) 1983-11-10
PH19579A (en) 1986-05-26
ZA8118B (en) 1982-01-27
CA1155108A (en) 1983-10-11

Similar Documents

Publication Publication Date Title
ES486786A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
ES508286A0 (es) Un procedimiento para la preparacion de derivados de imidazolil-propanol.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES516472A0 (es) Un procedimiento para la preparacion de derivados de 2-fenileta-nolamina.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES507667A0 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES519057A0 (es) Un procedimiento para la preparacion de derivados de caprolactama.
ES507506A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES515158A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES498938A0 (es) Procedimiento para la preparacion de corticoides de anillo a reducido.
ES504790A0 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES501339A0 (es) Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno.
ES507468A0 (es) Procedimiento para la preparacion de acilureas.
ES481102A0 (es) Un procedimiento para la preparacion de derivados de la in- danona.
ES504577A0 (es) Un procedimiento para la preparacion de derivados de piridazinona.
ES503338A0 (es) Un procedimiento para la preparacion de derivados de bis-hidroxibencilo.
ES505920A0 (es) Un procedimiento para la preparacion de derivados de isonicotinanilida.
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES514335A0 (es) Un procedimiento para la preparacion de guanidinas.
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES506034A0 (es) Un procedimiento para la preparacion de n-carboxialquil-dipeptidos.
ES499443A0 (es) Un procedimiento para la preparacion de derivados de 2-desoxi-3-5-di-o-alquilcarbonil-5-fluorurina.
ES498798A0 (es) Un procedimiento para la preparacion de derivados de imidazolhidrazona.